Recurrent venous thromboembolism (VTE) is associated with increased morbidity and
mortality. This risk is lowered by anticoagulation, with a large effect in the initial phase …

Post-thrombotic syndrome (PTS) is a frequent and burdensome complication of deep vein
thrombosis (DVT). There is no objective, criterion standard test to diagnose PTS. However …

To optimize patient outcomes with anticoagulation for venous thromboembolism (VTE), it is
essential to assess patients for their recurrence risk. In this article, I will review the impact of …

Background: About 30% of patients with an episode of adequately treated deep venous
thrombosis (DVT) develop the postthrombotic syndrome (PTS) within 2 years. During …

Venous thromboembolism (VTE) occurs for the first time in≈ 100 persons per 100,000 each
year in the United States, and rises exponentially from< 5 cases per 100,000 persons< 15 …

Background Pulmonary embolism (PE) is associated with a higher long-term mortality than
deep vein thrombosis (DVT). This association may be related to inadequate antithrombotic …

Among life-threatening cardiovascular diseases, pulmonary embolism (PE) is the third most
common after myocardial infarction and stroke. PE is a manifestation of venous …

Background We aimed to determine the risk of recurrence for symptomatic venous
thromboembolism (VTE) provoked by different transient risk factors. Data Sources MEDLINE …

Background Reported post-thrombotic syndrome (PTS) rates may be confounded by
including patients with a history of deep venous thrombosis (DVT) before the index event …

In patients with venous thromboembolism (VTE), assessment of the risk of fatal recurrent
VTE and fatal bleeding during anticoagulation may help to guide intensity and duration of …